|
|
||||||||
The Journal of Immunology, Vol 147, Issue 9 2892-2901, Copyright © 1991 by American Association of Immunologists
ARTICLES |
KA Clouse, LM Cosentino, KA Weih, SW Pyle, PB Robbins, HD Hochstein, V Natarajan and WL Farrar
Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892.
Results and conclusions concerning the ability of HIV glycoprotein (gp) 120 to stimulate monokine secretion have been equivocal, based on observations using natural gp120 derived from infected human cells and a Chinese hamster ovary (CHO) cell-derived recombinant fusion protein. Current studies were designed to determine whether differences in recombinant gp120 proteins could result in failure to trigger monokine production. We found that natural gp120 could stimulate monocytes to release TNF-alpha, IL-1 beta, IL-6, and granulocyte-macrophage-CSF, and this effect could be blocked with soluble CD4. Full-length rgp120 either expressed from an adenovirus vector and purified from infected human cells, or derived from CHO cells, could function similarly. In contrast, full-length recombinant envelope protein expressed in a baculovirus system and a CHO cell-derived recombinant fusion protein tested previously, consistently failed to stimulate monokine production. The stimulatory capacity of both natural and full-length CHO cell-derived gp120 was eliminated by heating at 100 degrees C, and could be blocked with excess CHO cell-derived gp120 fusion protein. Inasmuch as the baculovirus-expressed gp120 and the CHO cell-derived recombinant fusion protein can bind to CD4, these results suggest that HIV gp120 binding to CD4 on the monocyte surface may of itself be insufficient for stimulation of monokine secretion. Therefore, primary protein structure, as well as posttranslational protein modifications, may determine this activity.
This article has been cited by other articles:
![]() |
G. R. Campbell, J. D. Watkins, K. K. Singh, E. P. Loret, and S. A. Spector Human Immunodeficiency Virus Type 1 Subtype C Tat Fails To Induce Intracellular Calcium Flux and Induces Reduced Tumor Necrosis Factor Production from Monocytes J. Virol., June 1, 2007; 81(11): 5919 - 5928. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, J. Drenkow, C. S. R. Lankford, D. M. Frucht, R. L. Rabin, T. R. Gingeras, C. Venkateshan, F. Schwartzkopff, K. A. Clouse, and A. I. Dayton HIV regulation of the IL-7R: a viral mechanism for enhancing HIV-1 replication in human macrophages in vitro J. Leukoc. Biol., June 1, 2006; 79(6): 1328 - 1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lee, B. Tomkowicz, B. D. Freedman, and R. G. Collman HIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways J. Leukoc. Biol., October 1, 2005; 78(4): 1016 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ji, G. K. Sahu, V. L. Braciale, and M. W. Cloyd HIV-1 induces IL-10 production in human monocytes via a CD4-independent pathway Int. Immunol., June 1, 2005; 17(6): 729 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Kirkley and F. A. Robey Inhibition of U937 Cytokine Secretion by HIV-1 gp120 C4-Derived Peptide Constructs Journal of Bioactive and Compatible Polymers, May 1, 2004; 19(3): 173 - 195. [Abstract] [PDF] |
||||
![]() |
J. M. Fakruddin and J. Laurence HIV Envelope gp120-mediated Regulation of Osteoclastogenesis via Receptor Activator of Nuclear Factor {kappa}B Ligand (RANKL) Secretion and Its Modulation by Certain HIV Protease Inhibitors through Interferon-{gamma}/RANKL Cross-talk J. Biol. Chem., November 28, 2003; 278(48): 48251 - 48258. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lee, Q.-H. Liu, B. Tomkowicz, Y. Yi, B. D. Freedman, and R. G. Collman Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways J. Leukoc. Biol., November 1, 2003; 74(5): 676 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Lane, J. Liu, P. J. Bock, D. Schols, M. J. Coffey, R. M. Strieter, P. J. Polverini, and D. M. Markovitz Interleukin-8 and Growth-Regulated Oncogene Alpha Mediate Angiogenesis in Kaposi's Sarcoma J. Virol., October 11, 2002; 76(22): 11570 - 11583. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Choe, D. J. Volsky, and M. J. Potash Induction of Rapid and Extensive beta -Chemokine Synthesis in Macrophages by Human Immunodeficiency Virus Type 1 and gp120, Independently of Their Coreceptor Phenotype J. Virol., November 15, 2001; 75(22): 10738 - 10745. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okuda, K.-Q. Xin, A. Haruki, S. Kawamoto, Y. Kojima, F. Hirahara, H. Okada, D. Klinman, and K. Hamajima Transplacental Genetic Immunization After Intravenous Delivery of Plasmid DNA to Pregnant Mice J. Immunol., November 1, 2001; 167(9): 5478 - 5484. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Lane, R. M. Strieter, M. J. Coffey, and D. M. Markovitz Human Immunodeficiency Virus Type 1 (HIV-1)-Induced GRO-{alpha} Production Stimulates HIV-1 Replication in Macrophages and T Lymphocytes J. Virol., July 1, 2001; 75(13): 5812 - 5822. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hori, P. R. Burd, K. Furuke, J. Kutza, K. A. Weih, and K. A. Clouse Human Immunodeficiency Virus-1-Infected Macrophages Induce Inducible Nitric Oxide Synthase and Nitric Oxide (NO) Production in Astrocytes: Astrocytic NO as a Possible Mediator of Neural Damage in Acquired Immunodeficiency Syndrome Blood, March 15, 1999; 93(6): 1843 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mengozzi, C. De Filippi, P. Transidico, P. Biswas, M. Cota, S. Ghezzi, E. Vicenzi, A. Mantovani, S. Sozzani, and G. Poli Human Immunodeficiency Virus Replication Induces Monocyte Chemotactic Protein-1 in Human Macrophages and U937 Promonocytic Cells Blood, March 15, 1999; 93(6): 1851 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lien, P. Aukrust, A. Sundan, F. Muller, S. S. Froland, and T. Espevik Elevated Levels of Serum-Soluble CD14 in Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Correlation to Disease Progression and Clinical Events Blood, September 15, 1998; 92(6): 2084 - 2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, G. Roderiquez, T. Oravecz, and M. A. Norcross Cytokine Regulation of Human Immunodeficiency Virus Type 1 Entry and Replication in Human Monocytes/Macrophages through Modulation of CCR5 Expression J. Virol., September 1, 1998; 72(9): 7642 - 7647. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. De, C. N.S. Venkateshan, P. Seth, D. Carleton Gajdusek, and C. J. Gibbs Jr Adenovirus-Mediated Human Immunodeficiency Virus-1 Nef Expression in Human Monocytes/Macrophages and Effect of Nef on Downmodulation of Fcgamma Receptors and Expression of Monokines Blood, March 15, 1998; 91(6): 2108 - 2117. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moses, J. Nelson, and G. C. Bagby Jr The Influence of Human Immunodeficiency Virus-1 on Hematopoiesis Blood, March 1, 1998; 91(5): 1479 - 1495. [Full Text] [PDF] |
||||
![]() |
U. Junker, J. J. Moon, C. S. Kalfoglou, I. Sniecinski, S. J. Forman, J. A. Zaia, H. Kaneshima, and E. Bohnlein Hematopoietic Potential and Retroviral Transduction of CD34+Thy-1+ Peripheral Blood Stem Cells From Asymptomatic Human Immunodeficiency Virus Type-1-Infected Individuals Mobilized With Granulocyte Colony-Stimulating Factor Blood, June 15, 1997; 89(12): 4299 - 4306. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bour, C. Perrin, H. Akari, and K. Strebel The Human Immunodeficiency Virus Type 1 Vpu Protein Inhibits NF-kappa B Activation by Interfering with beta TrCP-mediated Degradation of Ikappa B J. Biol. Chem., May 4, 2001; 276(19): 15920 - 15928. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |